These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19585495)

  • 1. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
    Castro FA; Haimila K; Sareneva I; Schmitt M; Lorenzo J; Kunkel N; Kumar R; Försti A; Kjellberg L; Hallmans G; Lehtinen M; Hemminki K; Pawlita M
    Int J Cancer; 2009 Oct; 125(8):1851-8. PubMed ID: 19585495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
    Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
    Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
    J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri.
    Beskow AH; Gyllensten UB
    Int J Cancer; 2002 Oct; 101(6):526-31. PubMed ID: 12237892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.
    Ghaderi M; Nikitina Zake L; Wallin K; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
    Hum Immunol; 2001 Oct; 62(10):1153-8. PubMed ID: 11600224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students.
    Mahmud SM; Robinson K; Richardson H; Tellier PP; Ferenczy AS; Roger M; Coutlee F; Franco EL
    J Infect Dis; 2007 Jul; 196(1):82-90. PubMed ID: 17538887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
    Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
    Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
    Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
    Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levels.
    Ramachandran D; Schürmann P; Mao Q; Wang Y; Bretschneider LM; Speith LM; Hülse F; Enßen J; Bousset K; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Tarbiat J; Runnebaum I; Dürst M; Hein A; Koch M; Ruebner M; Ekici A; Beckmann MW; Fasching PA; Luyten A; Petry KU; Hillemanns P; Dörk T
    Int J Cancer; 2020 Nov; 147(9):2458-2468. PubMed ID: 32580243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
    Chen D; Gyllensten U
    Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study of susceptibility loci for cervical cancer.
    Chen D; Juko-Pecirep I; Hammer J; Ivansson E; Enroth S; Gustavsson I; Feuk L; Magnusson PK; McKay JD; Wilander E; Gyllensten U
    J Natl Cancer Inst; 2013 May; 105(9):624-33. PubMed ID: 23482656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.
    Gokhale P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Salvi V; Mania-Pramanik J
    Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S36-43. PubMed ID: 25673541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix.
    Sastre-Garau X; Loste MN; Vincent-Salomon A; Favre M; Mouret E; de la Rochefordiere A; Durand JC; Tartour E; Lepage V; Charron D
    Int J Cancer; 1996 Jun; 69(3):159-64. PubMed ID: 8682580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese.
    Chan PK; Cheung TH; Lin CK; Siu SS; Yim SF; Lo KW; Cheung JL; Tam AO; Tang JW
    J Med Virol; 2007 Jul; 79(7):970-6. PubMed ID: 17516530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
    Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S
    Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host and viral genetics and risk of cervical cancer: a review.
    Hildesheim A; Wang SS
    Virus Res; 2002 Nov; 89(2):229-40. PubMed ID: 12445662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women.
    Cervantes J; Lema C; Valentina Hurtado L; Andrade R; Hurtado Gomez L; Torrico L; Zegarra L; Quiroga G; Asturizaga D; Dulon A; Prada R; Panoso W; Yashiki S; Fujiyoshi T; Sonoda S
    Hum Immunol; 2003 Sep; 64(9):890-5. PubMed ID: 12941545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.
    Thakur N; Hussain S; Kohaar I; Tabassum R; Nasare V; Tiwari P; Batra S; Bhambhani S; Das BC; Basir SF; Bharadwaj D; Bharadwaj M
    Biomarkers; 2009 Jun; 14(4):219-25. PubMed ID: 19489683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphisms in the DNA repair genes in HPV-positive cervical cancer.
    Bajpai D; Banerjee A; Pathak S; Thakur B; Jain SK; Singh N
    Eur J Cancer Prev; 2016 May; 25(3):224-31. PubMed ID: 25812040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.